Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Cell and gene therapy 4

Cell and Gene Therapy

Biohaven's Troriluzole; Daiichi/ AZ's Enhertu; Fujifilm Manufacturing Units

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Biohaven’s Troriluzole Failure; Daiichi/ AZ’s Enhertu; Fujifilm & Manufacturing Spree; J&J’s Darzalex Faspro

Biohaven's Troriluzole Dwindles Again In Alzheimer’s After Anxiety Biohaven Pharmaceuticals had put too much faith in its third-generation prodrug, Troriluzole. The company has tested the efficacy of the drug in more than one indication, including generalized anxiety disorder (GAD), obsessive-compulsive disorder, spinocerebellar ataxia and Alzheimer’s disease (AD). However, it seems the drug continues to disappoint the company one after another. After the drug failed to produce better outcomes in anxiety, failed to meet primary outcomes in OCD, the company announced that their chemical entity that modulates glutamate, the most abundant excitatory neurotran...

Explore More...

gene therapy in oncology

Gene Therapy in Oncology: Innovation to Commercialization

The Business Cocktail

Inozyme Raises $67M; Shanghai Miracogen partners with Synaffix; EdiGENE raises $15M; Antengene announces its expansion

Gene Therapy in Oncology

The promising Pipeline for Gene Therapy In Oncology

stem cell therapy

Notizia

merck

The Business Cocktail

mRNA

BioNTech lines up $800M; Deerfield remunerates; Britain’s Smith & Nephew to acquire Osiris

The Business Cocktail

CRISPR

Notizia

CRISPR

A CRISPR WAY TO USE STEM CELLS

CRISPR

CRISPR proves to be a blessing for LASSA fever

Kidney Cancer

Notizia

Diabetes

Human cells reprogrammed to create insulin in diabetic mice

Peloton Therapeutics

Neurogene raises $68.5M; AbbVie and Teneobio sign deal; 5AM Ventures nets

Genentech remunerates Xencor; XPrize upraises fund; GSK gambles

Kidney Cancer

Notizia

lung cancer

Molecular Profiling Could Help in Early Lung Cancer Detection: Study

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly